Mr. Dimitris Anagnostakis was born in 1964. He studied Pharmaceutical Science at the University of Patras.
He joined Boehringer Ingelheim Ellas SA in 1991 with specialization in hospital products. During 1996-2002, he took on various positions in the company’s department of Pharmaceutical Marketing for the sector of Cardiology medicine, responsible for the launching of various new products in the treatment field of thrombolysis and hypertension. In the following two years (2002-2004), he becomes Head of Hospital Business Unit. After the company’s restructuring, he becomes Head of Marketing & Oncology Business in 2004, a position held until 2013.
For the subsequent period, he is been relocated to the Company’s head office in Ingelheim, Germany, as Regional Business Manager for Italy, France and Spain. Since July 2014, he is the President and Managing Director of Boehringer Ingelheim Ellas SA for Greece and Cyprus.
On behalf of Boehringer Ingelheim Ellas, Dimitris Anagnostakis is a member of Directors of Hellenic - German Chamber of Commerce (AHK), and Chairman of the Health Committee of AHK.
He is also member of the Board of Directors of the Hellenic Association of Pharmaceutical Companies (SFEE) and holds the position of Vice President responsible for Scientific Affairs and Clinical trials.
14.35 - 15.20
The EU Pharma Strategy and the Challenges for the Greek Healthcare Sector
Ahrweiler Hall | European Cultural Centre of Delphi
Programming Partner: Hellenic Association of Pharmaceutical Companies (SFEE)